Kinross Gold (KGC) Generates Record Free Cash Flow in Strong Q2 Performance

Kinross Gold Corporation (NYSE:KGC) is one of the best Canadian gold stocks to buy according to hedge funds. On July 30, the company released its Q2 2025 financial and operational results, terming the quarter “strong.”

The company reported record free cash flow of approximately $647 million for the quarter up from $346 million in the prior-year quarter. Revenue grew by 42% year-over-year to $1.73 billion in the quarter and net earnings more than doubled to $530.7 million ($0.43 per share). Adjusted net earnings came in at $541 million ($0.44 per share). Regarding production and operations, Kinross produced 513,000 gold equivalent ounces during the quarter. The average realized gold price was $3,284 per ounce, a 40% increase from Q2 2024. Meanwhile, the production cost of sales was $1,080 per gold equivalent ounce sold, and all-in sustaining cost (AISC) reached $1,493 per ounce.

The company reaffirmed its 2025 guidance: 2 million ounces production, AISC of $1,500/oz, and cost of sales $1,120/oz. Management expects production to remain level through the year, with Q3 and Q4 output forecast at approximately 500,000 ounces each.

Kinross Gold Corporation (NYSE:KGC) is a senior Canadian gold producer with a global footprint. It explores, develops, and operates gold mines across the United States, Brazil, Chile, Mauritania, and Canada. Flagship assets include the Paracatu mine in Brazil and the Tasiast mine in Mauritania, both known for large-scale, low-cost production. Kinross generates its primary revenue from gold bullion, refined from open-pit and heap leach operations supported by advanced processing facilities.

While we acknowledge the potential of KGC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Best Depressed Stocks to Buy in 2025 and Top 10 Medical AI Companies to Buy According to Analysts.

Disclosure: None. This article is originally published at Insider Monkey.